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6 times in the southern clade.
“This difference is due
primarily to the disparity in the
number of new species
created per progenitor that
diversified,” they say.
However, three of these
four southern clade
speciation events resulted in
widespread species that now
range across much of eastern
North America and a species
that is restricted to the
Atlantic coastal plain. “The
fourth event led to the
splitting of a progenitor into
three species that all now
inhabit this same coastal
plain,” they say.
Importantly, the differences
between the northern and
southern clades suggests that
local biogeography and
climate change were critical
for the macroevolutionary
dynamics of these organisms.
“Both the northern and
southern clades showed a
recent elevation in speciation
rate and, as expected, the
northern clade showed a
substantially greater increase
than the southern clade,” the
authors say.
Changing climates may be
more likely to drive members
of some groups with particular
features extinct, simply shift
the ranges of others, and
spark diversification in still
others, the authors say.
“Focused studies comparing
clades with different
responses will allow us to to
determine how biogeography
may interact with the
ecological and phenotypic
properties of various clade
members to determine these
responses,” they say. “Such
studies will be invaluable as
guides to conservation efforts
as we try to anticipate species’
response to climate change in
the future.”
Although for many species,
climate change spells trouble,
for others, local factors and
evolutionary mechanisms may
provide an opportunity for
exploitation of a changing
climatic world.
Magazine
R235
Quick guide
Intestinal
microbiota
Claudia Lupp and B. Brett Finlay
Who are they? Our intestinal
system harbors an enormous
number of non-pathogenic
bacteria, eukaryotic
microorganisms, archaea, viruses
and bacteriophages, comprising
a community collectively referred
to as the intestinal microbiota.
Bacteria account for the majority
of these microorganisms: their
total number in the human gut is
estimated at 1014 cells, which
roughly equals the number of
human cells in our body. Over 500
different bacterial species build a
dynamic community consisting of
both persistent and transient
members. The microbial
community structure is influenced
by genotype, immune status, age,
diet and environmental factors,
and consequently varies among
different people. Also, changes in
nutrient availability and oxygen
concentration along the
gastrointestinal tract are reflected
in regional differences in bacterial
concentrations and community
composition. 
Our relationship with the entire
intestinal microbiota can be
described as symbiotic, with both
partners benefiting. At present,
however, direct evidence for the
beneficial nature of only a few
species within the community
exists. Thus, many bacterial
species may be classified as
commensals, as they benefit from
the nutrient-rich environment in
the intestine yet their presence
has no beneficial consequence to
the host. The intestinal microbiota
also harbors opportunistic
pathogens, which have the
potential to cause disease if the
human host defenses are
compromised.
Where do they come from? The
association of bacteria with the
intestinal tracts of animals is far
older than human life itself, and
the bacterial communities have
presumably co-evolved with their
animal and human hosts. Our first
encounter with microorganisms
occurs in the birth canal, when
the colonization of the formerly
sterile gastrointestinal tract is
initiated by the maternal vaginal
and intestinal microbiota.
Interactions with humans and
animals, food ingestion, and other
environmental contacts define
successive gastrointestinal
colonization events, establishing
persistent community members
and periodically introducing
transient bacterial species,
resulting in a dynamic association
throughout life.
What do they do? The intestinal
microbiota, together with gut
epithelial and immune cells,
comprise a complex ecosystem
that is important for many
physiological processes.
Intestinal epithelial cells with their
junctional complexes, the
associated apical mucus layer,
and the luminal and mucosa-
associated bacteria provide a
selective physical barrier between
the lumen and systemic sites,
which allows the absorption of
water, electrolytes and nutrients
but discourages the translocation
of harmful microbial products.
Thus, treatments affecting the
microbiota, as for example
antibiotics, increase the chance
of host colonization by infectious
agents. 
The intestinal microbiota
improves digestion and
absorption of nutrients by
increasing the intestinal surface
area and through fermentation of
otherwise non-digestible food
components, such as starch and
fibre, thereby liberating additional
energy for the host. The presence
of bacteria in the intestine
promotes the establishment of a
resident population of
immunocytes, keeping the
intestinal epithelium in a state of
‘physiological inflammation’,
which is required for the
generation of a rapid defense
response against invading
pathogens. Intestinal bacteria
also actively prevent infection
with invading pathogens by
competing for nutrients, space
and host receptors, and by
secreting antimicrobial
substances.
What would we do without
them? Because we are
constantly exposed to the
environment, and thus to
microorganisms, we cannot avoid
bacterial colonization. Nor should
we, as studies conducted in
germ-free animals suggest. For
example, when compared to
conventionally raised rodents,
their germ-free counterparts
excrete more calories, require a
higher energy intake to maintain
their body weight, and need
vitamin K and in some cases
special vitamin B supplements.
Germ-free mice also demonstrate
morphological abnormalities of
the intestine and gut motor
dysfunction. Furthermore, the
intestinal immune system is
immature at birth and requires
exposure to colonizing bacteria in
order to fully develop. Germ-free
animals thus display an enhanced
susceptibility to enteric infections
and are prone to develop
allergies.
How do we tolerate them? As
long as we are healthy, the
intestinal immune response to
bacteria or bacterial products has
two principal outcomes:
tolerance to the microbiota and
response to pathogenic bacteria.
There are many contributing
factors allowing the immune
system to distinguish between
pathogenic and non-pathogenic
bacterial stimuli to ensure the
proper response. The most
significant distinguishing feature
is the ability of pathogenic
bacteria to invade spaces that
are usually devoid of bacteria,
such as epithelial crypts, the
epithelial surface, epithelial cells
and the lamina propria. 
Tolerance to the intestinal
microbiota is thus maintained
partially by ignorance of the host
to bacterial products in the
lumen. In addition, the microbiota
actively places constraints on the
host immune system by down-
regulating inflammatory immune
responses. Maintaining a fine
balance between immune
tolerance and response is
extremely important, as
hypersensitive responses to the
microbiota have been implicated
as the cause of inflammatory
bowel disorders such as Crohn’s
disease and ulcerative colitis.
What if they turn against us?
We normally coexist peacefully
with our microbiota. However,
any factor disturbing the
intestinal ecosystem has the
potential to lead to disease. For
example antibiotic treatment,
infection, surgery, chemotherapy
or other medical procedures or
diseases that weaken the immune
system may cause the escape of
opportunistic pathogens from the
intestinal lumen, resulting in
systemic infection. While the net
metabolic activity of the microbial
community in a healthy host
appears to be health-promoting,
individual metabolic products
may be toxic and have been
connected to gastrointestinal
cancers. Epidemiological studies
have linked an altered
composition of the intestinal
microbiota with the development
of atopic eczema, arthritis and
allergic diseases.
How can we support them?
Many factors such as our diet,
diseases and drug treatments
can disturb the intestinal
microbiota composition and thus
cause disease or intestinal
discomfort. To alleviate the
symptoms of conditions linked to
an altered microbiota, treatments
are being developed with the
general goal of increasing the
number of beneficial bacteria at
the cost of those bacteria having
neutral or detrimental effects. The
major approaches are: prebiotics,
which are dietary supplements
that are preferably metabolized
by health-promoting bacteria;
probiotics, which are based on
direct administration of beneficial
bacteria; or synbiotics, which is a
combination of these.
What else do we need to learn
about them? Because our
intestinal microbiota is incredibly
diverse and dynamic, and we
each host a unique community of
bacteria, it is problematic to
interpret epidemiological data and
thus to determine the
cause–effect relationship of
diseases and an altered
microbiota. Additionally, most
intestinal bacteria are strictly
anaerobic and/or are not
culturable in the laboratory,
making it difficult or even
impossible to access them
experimentally. To overcome
these constraints, gnotobiotics —
the study of germ-free or ex-
germ-free animals that have been
colonized with a defined
microbiota usually consisting of
one or a few bacterial species —
have been used to elucidate many
molecular and physiological
aspects of beneficial host-
bacteria interactions. 
However, questions concerning
bacteria–bacteria interactions
within the intestinal microbial
community cannot be addressed
using these techniques, and it is
most likely that the impact of a
community consisting of more
than 500 diverse members is
different from that of a single
bacterial species. An alternative
approach is to use culture-
independent molecular methods,
such as sequencing bacterial 16S
rRNA genes, to define the
microbial community. However,
molecular information does not
necessarily relate to bacterial
physiology. Thus combining
existing methods and developing
new methods are necessary to
address the many complex
questions that remain to be
answered concerning our
microbial gut community.
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